Revealing Global Regulatory Perturbations across Human Cancers

被引:161
作者
Goodarzi, Hani [1 ,2 ]
Elemento, Olivier [1 ,2 ]
Tavazoie, Saeed [1 ,2 ]
机构
[1] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA
[2] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA
基金
美国国家卫生研究院;
关键词
B-CELL LYMPHOMA; GENE-EXPRESSION; TRANSCRIPTION FACTOR; BURKITT-LYMPHOMA; OVARIAN-CANCER; NF-Y; DIFFERENTIATION; ACTIVATION; PROFILES; ALPHA;
D O I
10.1016/j.molcel.2009.11.016
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
The discovery of pathways and regulatory networks whose perturbation contributes to neoplastic transformation remains a fundamental challenge for cancer biology. We show that such pathway perturbations, and the cis-regulatory elements through which they operate, can be efficiently extracted from global gene expression profiles. Our approach utilizes information-theoretic analysis of expression levels, pathways, and genomic sequences. Analysis across a diverse set of human cancers reveals the majority of previously known cancer pathways. Through de novo motif discovery we associate these pathways with transcription-factor binding sites and miRNA targets, including those of E2F, NF-Y, p53, and let-7. Follow-up experiments confirmed that these predictions correspond to functional in vivo regulatory interactions. Strikingly, the majority of the perturbations, associated with putative cis-regulatory elements, fall outside of known cancer pat ways. Our study provides a systems-level dissection of regulatory perturbations in cancer-an essential component of a rational strategy for therapeutic intervention and drug-target discovery.
引用
收藏
页码:900 / 911
页数:12
相关论文
共 53 条
[1]
Intracellular signal transduction pathway proteins as targets for cancer therapy [J].
Adjei, AA ;
Hidalgo, M .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (23) :5386-5403
[2]
ARORA KK, 1988, J BIOL CHEM, V263, P17422
[3]
Gene Ontology: tool for the unification of biology [J].
Ashburner, M ;
Ball, CA ;
Blake, JA ;
Botstein, D ;
Butler, H ;
Cherry, JM ;
Davis, AP ;
Dolinski, K ;
Dwight, SS ;
Eppig, JT ;
Harris, MA ;
Hill, DP ;
Issel-Tarver, L ;
Kasarskis, A ;
Lewis, S ;
Matese, JC ;
Richardson, JE ;
Ringwald, M ;
Rubin, GM ;
Sherlock, G .
NATURE GENETICS, 2000, 25 (01) :25-29
[4]
T-profiler: scoring the activity of predefined groups of genes using gene expression data [J].
Boorsma, A ;
Foat, BC ;
Vis, D ;
Klis, F ;
Bussemaker, HJ .
NUCLEIC ACIDS RESEARCH, 2005, 33 :W592-W595
[5]
IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA [J].
Calfon, M ;
Zeng, HQ ;
Urano, F ;
Till, JH ;
Hubbard, SR ;
Harding, HP ;
Clark, SG ;
Ron, D .
NATURE, 2002, 415 (6867) :92-96
[6]
Immunohistochemical expression of the transcription factor DP-1 and its heterodimeric partner E2F-1 in non-Hodgkin lymphoma [J].
Chan, JA ;
Olvera, M ;
Lai, R ;
Naing, W ;
Rezk, SA ;
Brynes, RK .
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2002, 10 (04) :322-326
[7]
Cell adhesion and chemotaxis in prostate cancer metastasis to bone: a minireview [J].
Cooper, CR ;
Pienta, KJ .
PROSTATE CANCER AND PROSTATIC DISEASES, 2000, 3 (01) :6-12
[8]
Cutroneo KR, 2006, CRIT REV EUKAR GENE, V16, P23
[9]
Vascular endothelial growth factor expression in ovarian cancer: A model for targeted use of novel therapies? [J].
Duncan, Timothy J. ;
Al-Attar, Ahmad ;
Rolland, Phil ;
Scott, Ian V. ;
Deen, Suha ;
Liu, David T. Y. ;
Spendlove, Ian ;
Durrant, Lindy G. .
CLINICAL CANCER RESEARCH, 2008, 14 (10) :3030-3035
[10]
Gene expression in the urinary bladder:: A common carcinoma in situ gene expression signature exists disregarding histopathological classification [J].
Dyrskjot, L ;
Kruhoffer, M ;
Thykjaer, T ;
Marcussen, N ;
Jensen, JL ;
Moller, K ;
Orntoft, TF .
CANCER RESEARCH, 2004, 64 (11) :4040-4048